Total Payments
$3,312
2024 Payments
$43.15
Companies
7
Transactions
14
Medicare Patients
10,278
Medicare Billing
$1.4M
Payment Breakdown by Category
Consulting$1,500 (45.3%)
Travel$1,287 (38.9%)
Food & Beverage$489.97 (14.8%)
Education$34.93 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,500 | 1 | 45.3% |
| Travel and Lodging | $1,287 | 3 | 38.9% |
| Food and Beverage | $489.97 | 8 | 14.8% |
| Education | $34.93 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $2,935 | 5 | $0 (2017) |
| Covidien LP | $260.55 | 2 | $0 (2019) |
| Genentech USA, Inc. | $38.66 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $25.00 | 1 | $0 (2024) |
| Mirati Therapeutics, Inc. | $21.00 | 1 | $0 (2023) |
| Novo Nordisk Inc | $18.15 | 1 | $0 (2024) |
| Acrotech Biopharma LLC | $13.93 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.15 | 2 | Novartis Pharmaceuticals Corporation ($25.00) |
| 2023 | $21.00 | 1 | Mirati Therapeutics, Inc. ($21.00) |
| 2021 | $13.93 | 1 | Acrotech Biopharma LLC ($13.93) |
| 2019 | $141.03 | 1 | Covidien LP ($141.03) |
| 2017 | $3,093 | 9 | Celgene Corporation ($2,935) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 07/07/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2019 | Covidien LP | LigaSure (Device) | Food and Beverage | In-kind items and services | $141.03 | General |
| Category: Vessel Sealing | ||||||
| 05/24/2017 | Celgene Corporation | Revlimid (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Hematology / Oncology | ||||||
| 05/18/2017 | Celgene Corporation | Revlimid (Drug) | Travel and Lodging | In-kind items and services | $586.41 | General |
| Category: Hematology / Oncology | ||||||
| 05/18/2017 | Celgene Corporation | Revlimid (Drug) | Travel and Lodging | In-kind items and services | $439.56 | General |
| Category: Hematology / Oncology | ||||||
| 05/18/2017 | Celgene Corporation | Revlimid (Drug) | Travel and Lodging | In-kind items and services | $261.40 | General |
| Category: Hematology / Oncology | ||||||
| 05/18/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $147.61 | General |
| Category: Hematology / Oncology | ||||||
| 05/17/2017 | Covidien LP | — | Food and Beverage | In-kind items and services | $119.52 | General |
| 03/27/2017 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: BioOncology | ||||||
| 03/23/2017 | Genentech USA, Inc. | Herceptin (Biological), Perjeta | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: BioOncology | ||||||
| 01/05/2017 | Genentech USA, Inc. | Herceptin (Biological), Perjeta | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 2,669 | 91,321 | $697,807 | $375,072 |
| 2022 | 48 | 2,606 | 87,226 | $775,732 | $395,780 |
| 2021 | 42 | 2,470 | 84,547 | $590,176 | $309,506 |
| 2020 | 40 | 2,533 | 82,495 | $669,097 | $327,721 |
Total Patients
10,278
Total Services
345,589
Medicare Billing
$1.4M
Procedure Codes
173
All Medicare Procedures & Services
173 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 40 | 6,180 | $163,770 | $112,552 | 68.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 297 | 709 | $107,059 | $64,428 | 60.2% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 38 | 51,000 | $76,500 | $43,338 | 56.7% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 19 | 15,600 | $62,400 | $35,871 | 57.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 54 | 270 | $71,820 | $27,044 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 71 | 104 | $21,216 | $13,932 | 65.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 84 | 248 | $29,760 | $11,648 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $13,548 | $6,671 | 49.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 232 | 868 | $14,756 | $6,584 | 44.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 172 | 540 | $12,420 | $5,530 | 44.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 98 | $13,230 | $5,453 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 78 | $7,800 | $4,691 | 60.1% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 15 | 84 | $11,004 | $4,178 | 38.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 94 | 303 | $11,211 | $3,287 | 29.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $5,567 | $3,004 | 54.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 37 | 242 | $9,196 | $2,875 | 31.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 195 | 460 | $2,300 | $2,244 | 97.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 102 | 163 | $4,727 | $2,178 | 46.1% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2023 | 37 | 105 | $4,620 | $2,141 | 46.3% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 99 | 161 | $5,474 | $2,013 | 36.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 99 | 126 | $3,906 | $1,862 | 47.7% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 22 | 118 | $4,248 | $1,804 | 42.5% |
| 82746 | Folic acid level, serum | Office | 2023 | 91 | 107 | $3,103 | $1,542 | 49.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 26 | 67 | $3,953 | $1,481 | 37.5% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 15 | 8,000 | $5,600 | $1,223 | 21.8% |
About Dr. Yijun Cheng, M.D
Dr. Yijun Cheng, M.D is a Hematology & Oncology healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013058213.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yijun Cheng, M.D has received a total of $3,312 in payments from pharmaceutical and medical device companies, with $43.15 received in 2024. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($1,500).
As a Medicare-enrolled provider, Cheng has provided services to 10,278 Medicare beneficiaries, totaling 345,589 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 173 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Williamsville, NY
- Active Since 02/09/2007
- Last Updated 12/11/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1013058213
Products in Payments
- Revlimid (Drug) $2,935
- LigaSure (Device) $141.03
- PLUVICTO (Drug) $25.00
- Herceptin (Biological) $24.08
- KRAZATI (Drug) $21.00
- Ozempic (Drug) $18.15
- Perjeta (Biological) $14.58
- BELEODAQ (Drug) $13.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Williamsville
Michael Krabak, Md, MD
Hematology & Oncology — Payments: $40,158
Hematology & Oncology $40,158
Dr. Saifuddin Soniwala, M.d, M.D
Hematology & Oncology — Payments: $22,854
Hematology & Oncology $22,854
Hong Liu, Md Phd, MD PHD
Hematology & Oncology — Payments: $10,708
Hematology & Oncology $10,708
Dr. Robert Setlik, M.d.,Ph.d, M.D.,PH.D
Hematology & Oncology — Payments: $5,055
Hematology & Oncology $5,055
Frederick Hong, Md, MD
Hematology & Oncology — Payments: $1,741
Hematology & Oncology $1,741
Dr. Robert Zielinski, Md, MD
Hematology & Oncology — Payments: $289.06
Hematology & Oncology $289.06